You just read:

New Analyses from Phase 3 Study 009 of Translarna™ (ataluren) in Patients with Cystic Fibrosis Presented at 39th European Cystic Fibrosis Conference

News provided by

PTC Therapeutics, Inc.

Jun 10, 2016, 10:30 ET